Business Context and Reporting Period
This Form 8-K filing by Revelation Biosciences, Inc. (REVB) reports on a special meeting of stockholders held on January 17, 2024. The company is an emerging growth company incorporated in Delaware with principal executive offices in San Diego, California.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance actions and stockholder voting results.
Material Changes and Voting Results
Stockholders approved two key proposals at the special meeting:
- Reverse Stock Split Authorization: The board was granted discretionary authority to effect a reverse stock split of outstanding common stock within one year. The split ratio may range from one-for-2 to a maximum of one-for-50, to be determined by the board without further stockholder approval.
- Adjournment Authority: Stockholders approved the adjournment of the meeting if insufficient proxies were present to approve the reverse stock split.
Voting Statistics:
- Shares Entitled to Vote: 6,297,303
- Shares Present/Represented: 2,244,048 (Constituting a quorum)
- Proposal 1 (Reverse Stock Split): 1,410,313 For; 831,173 Against; 2,562 Abstain.
- Proposal 2 (Adjournment): 1,676,035 For; 551,758 Against; 16,255 Abstain.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the context of the stock split. The primary contingency noted is the board's discretion to determine the exact split ratio within the approved range.
Investor Verification Checklist
- Verify the specific reverse stock split ratio once determined by the board of directors.
- Confirm the effective date of the reverse stock split, which must occur within one year of January 17, 2024.
- Review the company's subsequent filings for any updates on the implementation of the split.
- Check the current trading status of common stock (REVB) and warrants (REVBW) on The Nasdaq Stock Market LLC.